Polygonum
FDA Label NDC 60986-1022

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Marco Pharma International Llc. for the product Polygonum (NDC 60986-1022). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, otc - keep out of reach of children, suggested use, warnings, dosage & administration, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Polygonum Aviculare 1x

Acorus Calamus 1x

Rhus Toxicodendron 4xHPUS

Gnaphalium Polycephalum 2xHPUS

Rhododendron Chrysanthum 3xHPUS

Colocynthis 3xHPUS

Colchicum Autumnale 3xHPUS

Kali Iodatum 4xHPUS

Ichthyolum 3xHPUS

Symphytum Officinale 1XHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

Relief of pain in joints and muscles.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Suggested Use

Adults: take 30 drops in a glass of tepid water three to five times daily. For acute rheumatic symptoms, take 10 - 15 drops in waterevery hour. As maintenance take 30 drops two times daily. Children receive 1/2 or less of the adult amount.

Warnings

If pregnant or breast-feeding, consult a health professional before use.

Dosage & Administration

(Read Suggested Use Section)

Inactive Ingredients

Ethyl Alcohol (50.2% by vol.) and Water

Package Label.Principal Display Panel


Label (Polygonum100)

Label (Polygonum100)

MM1

* Please review the disclaimer below.